FDA Expands Approved Use of Stivarga (regorafenib) to Treat Hepatocellular Carcinoma

Article Link: FDA Expands Approved Use of Stivarga (regorafenib) to Treat Hepatocellular Carcinoma



Source: FDA New Drug Approvals